A comparative analysis of drug-induced DNA effects in a nitrogen mustard resistant cell line expressing sensitivity to nitrosoureas.
In the Walker 256 rat mammary carcinoma cell line, WR, resistance to nitrogen mustards (NM) is accompanied by collateral sensitivity to chloroethylnitrosoureas (CENUs). DNA-interstrand cross-links, DNA-protein cross-links, and sister chromatid exchange (SCE) induction were assayed in WR and the parent cell line (WS) after treatment with nitrogen mustard (HN2), phosphoramide mustard (PM), chlorozotocin (CLZ) and 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU). Treatment of cells with HN2 caused extensive levels of cross-links, approximately 50% of which were DNA-interstrand, equal in both WR and WS, whereas PM caused no detectable cross-links in either cell line. CLZ induced low levels of DNA-interstrand cross-links, similar in WR and WS, but no DNA-interstrand cross-links could be detected in either cell line after treatment with CCNU. Both CLZ and CCNU induced low levels of DNA-protein cross-links in both cell lines, though higher in WR than WS. There was no difference in the rate of removal of HN2-induced DNA-interstrand or DNA-protein cross-links or total CLZ-induced cross-links by the two cell lines, suggesting that differential repair was not relevant to the expression of resistance. Both HN2 and PM caused more SCEs in WS than in WR, whereas CLZ and CCNU induced more SCEs in WR. Thus, NM-induced SCEs were related to cell killing but not cross-linking, whilst CENU-induced SCEs were related to cell killing and DNA-protein but not DNA-interstrand cross-links. Furthermore, the collateral sensitivity of WR cells to CENUs was not due to the differential induction of DNA-interstrand cross-links or repair of total cross-links, or repair of total cross-links, although higher levels of DNA-protein cross-links occurred in WR, and these may be either a cause or a consequence of increased susceptibility of these cells to CENUs. Presumably NMs and CENUs have several distinct and separate macromolecular targets which result in differential cell killing. It is concluded that a range of lesions occurred after treatment of WR and WS cells with either NMs or CENUs and that, in these cell lines, there is no simple correlation between drug-induced cross-linking, SCE induction and cytotoxicity.
D000818:Animals; D002279:Carcinoma 256, Walker / Q000473:pathology; D002460:Cell Line; D003432:Cross-Linking Reagents / Q000494:pharmacology; D004247:DNA / Q000032:analysis*; D004305:Dose-Response Relationship, Drug; D004351:Drug Resistance; D008130:Lomustine / Q000494:pharmacology*; D008325:Mammary Neoplasms, Experimental / Q000473:pathology; D008466:Mechlorethamine / Q000494:pharmacology*; D009603:Nitroso Compounds / Q000494:pharmacology*; D010752:Phosphoramide Mustards / Q000494:pharmacology; D051381:Rats; D012854:Sister Chromatid Exchange / Q000187:drug effects; D013311:Streptozocin / Q000031:analogs & derivatives / Q000494:pharmacology; D013997:Time Factors
D003432:Cross-Linking Reagents; D009603:Nitroso Compounds; D010752:Phosphoramide Mustards; C030090:phosphoramide mustard; C007028:chlorozotocin; D008466:Mechlorethamine; D013311:Streptozocin; C041148:N-(2-chloroethyl)-N-nitrosoacetamide; D008130:Lomustine; D004247:DNA